Oncology Research2026，Vol.34Issue(4)：P.760-782,23.DOI:10.32604/or.2026.073156
ONX-0914 Suppresses Hormone-Sensitive Prostate Cancer by Promoting O-GlcNAcylation-Mediated Stabilization of TCF7L1
Peng Xian 1Zhenwei Feng 2Haitao Yu 3Hubin Yin 2Haonan Chen 4Tenglin Shi 4Xilai Li 2Chunlin Zhang 2Xuesong Bai 2Xin Gou 4Xinyuan Li 2Jie Li4
作者信息
- 1. Department of Urology,The First Affiliated Hospital of Chongqing Medical University,Chongqing,China Department of Urological Oncology,Chongqing University Cancer Hospital,Chongqing,China
- 2. Department of Urology,The First Affiliated Hospital of Chongqing Medical University,Chongqing,China Chongqing Key Laboratory of Molecular Oncology and Epigenetics,Chongqing,China
- 3. Chongqing Key Laboratory of Molecular Oncology and Epigenetics,Chongqing,China
- 4. Department of Urology,The First Affiliated Hospital of Chongqing Medical University,Chongqing,China
- 折叠
摘要
关键词
Prostate cancer/transcription factor 7-like 1(TCF7L1)/androgen receptor/O-GlcNAcylation/hexosamine biosynthetic pathway分类
医药卫生引用本文复制引用
Peng Xian,Zhenwei Feng,Haitao Yu,Hubin Yin,Haonan Chen,Tenglin Shi,Xilai Li,Chunlin Zhang,Xuesong Bai,Xin Gou,Xinyuan Li,Jie Li..ONX-0914 Suppresses Hormone-Sensitive Prostate Cancer by Promoting O-GlcNAcylation-Mediated Stabilization of TCF7L1[J].Oncology Research,2026,34(4):P.760-782,23.
